InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Harsch Mutya, Directrice Juridique et GC. Insider active across 1 companies, notably VYNE Therapeutics Inc.. Cumulatively, 10 filings have been logged. The latest transaction was disclosed on 31 March 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
€2,1313,630 shares@ €0.5870.011% mcap7.3% of flow
Common Stock
SEC:0001209191-22-022526:0·
075,000 shares0
Common Stock
SEC:0001209191-22-020065:0·
€1,3371,484 shares@ €0.90070.0069% mcap9.8% of flow
Common Stock
SEC:0001209191-22-000855·
€1,3371,484 shares@ €0.90070.0069% mcap4.5% of flow
Common Stock
SEC:0001209191-22-000855:0·
€1,7821,484 shares@ €1.20090.0092% mcap13.1% of flow
Common Stock
SEC:0001209191-21-058516·
€1,7821,484 shares@ €1.20090.0092% mcap6.1% of flow
Common Stock
SEC:0001209191-21-058516:0·
060,859 shares0
Common Stock
SEC:0001209191-21-054834·
060,859 shares0
Common Stock
SEC:0001209191-21-054834:0·
€10,5123,551 shares@ €2.96030.054% mcap77.1% of flow
Common Stock
SEC:0001209191-21-044977·
€10,5123,551 shares@ €2.96030.054% mcap35.8% of flow
Common Stock
SEC:0001209191-21-044977:0·
10 of 10 declarations
About Harsch Mutya
Mutya Harsch is the Chief Legal Officer and GC at VYNE Therapeutics Inc. She oversees the company's legal and compliance matters. Her role is essential in ensuring that the company adheres to current regulations.
